Loading...
COMOS – cancer therapies (RONC1-2)2018-10-19T14:53:57+00:00

RONC1 therapy against pancreatic cancer

COMOS combined with other immune therapeutic agents. RONC1 is Redbiotec’s lead oncology program.

RONC2 therapy against MSS colorectal cancer or ovarian cancer

COMOS combined with other immune therapeutic agents. RONC2 is Redbiotec’s second oncology program. Currently MSS colorectal and ovrian cancer are being evaluated as target.

Learn more about Redbiotec’s unique COMOS